These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34225982)

  • 1. The neuroendocrinology of the preoptic area in menopause: Symptoms and therapeutic strategies.
    Modi M; Dhillo WS
    Handb Clin Neurol; 2021; 179():455-460. PubMed ID: 34225982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin 3 Receptor Antagonism: A Novel Treatment for Menopausal Hot Flushes.
    Modi M; Dhillo WS
    Neuroendocrinology; 2019; 109(3):242-248. PubMed ID: 30504731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurokinin B and Neurokinin-3 Receptor Signaling: Promising Developments in the Management of Menopausal Hot Flushes.
    Modi M; Dhillo WS
    Semin Reprod Med; 2019 May; 37(3):125-130. PubMed ID: 31869840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes.
    Rance NE; Dacks PA; Mittelman-Smith MA; Romanovsky AA; Krajewski-Hall SJ
    Front Neuroendocrinol; 2013 Aug; 34(3):211-27. PubMed ID: 23872331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamatergic Neurokinin 3 Receptor Neurons in the Median Preoptic Nucleus Modulate Heat-Defense Pathways in Female Mice.
    Krajewski-Hall SJ; Miranda Dos Santos F; McMullen NT; Blackmore EM; Rance NE
    Endocrinology; 2019 Apr; 160(4):803-816. PubMed ID: 30753503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurokinin 3 receptor antagonism - the magic bullet for hot flushes?
    Prague JK; Dhillo WS
    Climacteric; 2017 Dec; 20(6):505-509. PubMed ID: 29040006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopause review: Emerging treatments for menopausal symptoms.
    Patel B; S Dhillo W
    Best Pract Res Clin Obstet Gynaecol; 2022 May; 81():134-144. PubMed ID: 34965909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurokinin 3 Receptor Antagonism Reveals Roles for Neurokinin B in the Regulation of Gonadotropin Secretion and Hot Flashes in Postmenopausal Women.
    Skorupskaite K; George JT; Veldhuis JD; Millar RP; Anderson RA
    Neuroendocrinology; 2018; 106(2):148-157. PubMed ID: 28380486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing Hot Flushes in Menopausal Women: A Review.
    Mallhi TH; Khan YH; Khan AH; Mahmood Q; Khalid SH; Saleem M
    J Coll Physicians Surg Pak; 2018 Jun; 28(6):460-465. PubMed ID: 29848424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Neural Circuit Underlying the Generation of Hot Flushes.
    Padilla SL; Johnson CW; Barker FD; Patterson MA; Palmiter RD
    Cell Rep; 2018 Jul; 24(2):271-277. PubMed ID: 29996088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurokinin 3 Receptor-Expressing Neurons in the Median Preoptic Nucleus Modulate Heat-Dissipation Effectors in the Female Rat.
    Mittelman-Smith MA; Krajewski-Hall SJ; McMullen NT; Rance NE
    Endocrinology; 2015 Jul; 156(7):2552-62. PubMed ID: 25825817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fezolinetant in the treatment of vasomotor symptoms associated with menopause.
    Depypere H; Lademacher C; Siddiqui E; Fraser GL
    Expert Opin Investig Drugs; 2021 Jul; 30(7):681-694. PubMed ID: 33724119
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review.
    Menown SJ; Tello JA
    Adv Ther; 2021 Oct; 38(10):5025-5045. PubMed ID: 34514552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-heat shock protein axis in menopausal hot flushes: neglected metabolic issues of chronic inflammatory diseases associated with deranged heat shock response.
    Miragem AA; Homem de Bittencourt PI
    Hum Reprod Update; 2017 Sep; 23(5):600-628. PubMed ID: 28903474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurokinin B administration induces hot flushes in women.
    Jayasena CN; Comninos AN; Stefanopoulou E; Buckley A; Narayanaswamy S; Izzi-Engbeaya C; Abbara A; Ratnasabapathy R; Mogford J; Ng N; Sarang Z; Ghatei MA; Bloom SR; Hunter MS; Dhillo WS
    Sci Rep; 2015 Feb; 5():8466. PubMed ID: 25683060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral investigational drugs currently in phase I or phase II for the amelioration of menopausal symptoms.
    Genazzani AR; Gaspard U; Foidart JM
    Expert Opin Investig Drugs; 2019 Mar; 28(3):235-247. PubMed ID: 30677323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurokinin 3 receptor antagonists - prime time?
    Prague JK
    Climacteric; 2021 Feb; 24(1):25-31. PubMed ID: 33135940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurokinin B pathway in the treatment of menopausal hot flushes.
    Anderson RA; Skorupskaite K; Sassarini J
    Climacteric; 2019 Feb; 22(1):51-54. PubMed ID: 30572747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The menopausal hot flush--anything new?
    Sturdee DW
    Maturitas; 2008 May; 60(1):42-9. PubMed ID: 18384981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New advances in menopause symptom management.
    Koysombat K; McGown P; Nyunt S; Abbara A; Dhillo WS
    Best Pract Res Clin Endocrinol Metab; 2024 Jan; 38(1):101774. PubMed ID: 37076317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.